ライフサイエンスコーパス: MVM

1 MVM infection also reduced the levels of cyclin B1 prote

2 MVM protein expression of GLUT-1, TAUT, SNAT-2 and LAT-1

3 MVM replication also benefits from the DNA damage respon

4 MVM use did not significantly affect all-cause mortality

5 MVM vesicle isolates contained endogenous amino acids al

6 MVM was similar for all tasks with no clear hierarchy be

7 endent initiation within the right-hand (5') MVM hairpin, we have characterized a HeLa cell factor wh

8 3, 4 and 5 (homogenate) and FATP2, 4, and 6 (MVM, BM) was determined by Western blotting.

9 A MVM including APRI+ALBI, age, sex, tumor type, and exten

10 ent Program database were used to generate a MVM to predict PHLF B+C.

11 ystem A-specific amino acid transport across MVM is higher in first trimester placenta compared to te

12 eled ingredient content and to compare adult MVM composition with Recommended Dietary Allowances (RDA

13 Adult MVMs were purchased while following a national sampling

14 and mineral overages were measured in adult MVMs, most of which already meet RDAs.

15 usted ingredient amounts are linked to adult MVMs reported in the NHANES 2003-2008 via the Dietary Su

16 tests (ICG clearance, ALICE), the APRI+ALBI MVM demonstrated equal predictive potential for PHLF B+C

17 Risk assessment through the APRI+ALBI MVM for PHLF B+C increases preoperative predictive accur

18 ication for the calculation of the APRI+ALBI MVM was designed.

19 In 620 patients, the APRI+ALBI MVM, trained in the National Surgical Quality Improvemen

20 The vector was packaged into an MVM lymphotropic capsid and inoculated into naive C3H/He

21 % amino acid sequence identity with CPV and MVM, respectively, but the degree of conservation of sur

22 Both MVM infection and MVM NS1 overexpression inhibited Rad9 S387 phosphorylati

23 The parvoviruses H-1, LuIII, and MVM target cancer cells; however, their relationship wit

24 essively infected only two of five; MVMp and MVM-G52 were ineffective in all five.

25 st oncolytic activity, LuIII, H-1, MVMp, and MVM-G52, were tested for the ability, at a low MOI, to p

26 empty vector-transduced (EV-transduced) and MVM-transduced or normal bone marrow cells.

27 with influenza A virus, Nyamanini virus, and MVM.

28 responsible for cohort studies that assessed MVMs should be encouraged to report available data on MV

29 t Rad9 failed to associate with chromatin at MVM APAR bodies.

30 Both MVM infection and MVM NS1 overexpression inhibited Rad9

31 PRV and both MVM strains generated more modest lytic effects and repl

32 Sindbis virus and both MVM strains showed highly tumor-selective actions in gli

33 ability of cyclin B1 RNA was not affected by MVM infection, the production of nascent cyclin B1 RNA w

34 We show that prevention by MVM of Chk1 activation leads to inhibition of homologous

35 ies the sialic acid structures recognized by MVM.

36 a native, though abbreviated, P38 cassette (MVM nt 1938 to 2072) confers significant levels of expre

37 In human HT-1080 cells, MVM vector random integration frequencies (neo(+) coloni

38 In contrast, MVM protein expression of GLUT 3 or SNAT4 was unaltered.

39 ontrolled, 2-by-2 factorial trial of a daily MVM and cocoa extract for prevention of cancer and cardi

40 study objective was to determine if a daily MVM decreases total invasive cancer among older adults.

41 COSMOS trial support the benefits of a daily MVM in preventing cognitive decline among older adults.

42 We observed no significant effect of a daily MVM on breast cancer (HR: 1.06; 95% CI: 0.79, 1.42) or c

43 We observed a protective effect of a daily MVM on lung cancer (HR: 0.62; 95% CI: 0.42, 0.92).

44 extract (500 mg flavanols/d) and/or a daily MVM supplement for cardiovascular disease and cancer pre

45 A daily MVM supplement, compared with placebo, did not significa

46 In COSMOS-Clinic, daily MVM supplementation leads to a significantly more favora

47 for healthcare providers to recommend daily MVM supplements to prevent cognitive decline.

48 OS cognitive substudies indicates that daily MVM significantly benefits both global cognition and epi

49 Participants were randomly assigned to daily MVM or placebo.

50 promote health, evidence on the use of daily MVMs on invasive cancer is limited.

51 During MVM infection, Chk1, a major downstream target of ATR, i

52 Chk1, however, was not activated during MVM infection even though viral genomes bearing bound RP

53 Inactivation of ATR during MVM infection leads to the accumulation of damaged DNA a

54 onally, overexpression of active Chk1 during MVM infection was found to re-establish the activating p

55 phosphorylation and Chk1 inactivation during MVM infection and NS1 overexpression revealing its role

56 tical target for cyclin B1 inhibition during MVM infection.IMPORTANCE Replication of the parvovirus m

57 evealing a dependence on MRE11 for efficient MVM replication.

58 e in infected nuclei at late times following MVM infection.

59 he significance of the VP2 cleavage step for MVM particle dynamics.

60 ata are not compelling concerning a role for MVMs in preventing cancer or cardiovascular disease morb

61 s accurate estimates of nutrient intake from MVMs based on measures of actual rather than labeled ing

62 hers and inspire new thinking for the future MVMs experiment optimization and product design.

63 We describe here how MVM, and specifically the main viral replication protein

64 We propose a digital-analog hybrid MVM architecture that achieves a high numerical precisio

65 In MVM, the sequence of this site is 5'-CTAT(black triangle

66 eats (CRISPR)-enzymatically inactive Cas9 in MVM-infected cells increased both cyclin B1 protein and

67 RISPR-catalytically inactive Cas9 (dCas9) in MVM-infected cells increased expression of both cyclin B

68 High-titer, replication-incompetent MVM vector stocks were generated with a two-plasmid tran

69 quired to prevent ATR activation, indicating MVM retargeted this kinase's activity during infection.

70 Thus, we conclude that during infection, MVM inhibition of Chk1 activation enhances viral replica

71 led substrates for each system into isolated MVM vesicles, and that of model substrates on 10 microm

72 We measured mean velocity magnitude (MVM), time averaged droplet number (TADN) and maximum dr

73 th placental maternal vascular malperfusion (MVM) lesions or current hypertension may be particularly

74 l vectors expressing MVNP and the MV matrix (MVM) genes.

75 ified recombinant RPA and PCNA, NS1-mediated MVM replication initiated from the 5' origin but not fro

76 icating FoxM1 as a critical target mediating MVM-induced cyclin B1 inhibition.

77 tiotrophoblast microvillous plasma membrane (MVM) and basal plasma membranes (BM) were isolated.

78 sms across the microvillous plasma membrane (MVM) of the syncytiotrophoblast, the transporting epithe

79 uman placental microvillous plasma membrane (MVM) vesicles.

80 syncytiotrophoblast microvillous membranes (MVMs).

81 In microvillous plasma membranes (MVMs) isolated from placentas of HF-fed animals, protein

82 d on a chimera between minute virus of mice (MVM) and LuIII, which expresses Borrelia burgdorferi out

83 e hairpin telomeres of Minute Virus of Mice (MVM) are extended and copied to create imperfectly palin

84 s particles known, the minute virus of mice (MVM) capsid, and experimentally analyzed its pathways of

85 tion by the parvovirus minute virus of mice (MVM) causes significant DNA damage and induces a potent

86 3'-terminal hairpin of minute virus of mice (MVM) contains sequence elements essential for both viral

87 is, the NS1 protein of minute virus of mice (MVM) first binds to a simple cognate recognition sequenc

88 autonomous parvovirus minute virus of mice (MVM) generates extensive DNA damage which facilitates vi

89 n at the 3' end of the minute virus of mice (MVM) genome and functions as an essential cofactor in th

90 at the two ends of the minute virus of mice (MVM) genome are dissimilar and are processed by differen

91 efold-symmetry axes in minute virus of mice (MVM) harbor central pores that penetrate through the vir

92 autonomous parvovirus minute virus of mice (MVM) has a compact DNA genome encoding a minimum number

93 Replication of minute virus of mice (MVM) induces a sustained cellular DNA damage response (D

94 tion of the parvovirus minute virus of mice (MVM) induces a sustained cellular DNA damage response (D

95 autonomous parvovirus minute virus of mice (MVM) induces cellular DNA breaks and localizes to such s

96 ral protein NS2 of the minute virus of mice (MVM) is required for efficient viral replication, althou

97 onse to infection with minute virus of mice (MVM) leads to activated p53; however, p21 levels are red

98 While the minute virus of mice (MVM) P4 promoter, which drives the viral nonstructural g

99 The parvovirus minute virus of mice (MVM) packages a single copy of its linear single-strande

100 The parvovirus minute virus of mice (MVM) packages predominantly negative-sense single strand

101 small-intron region of minute virus of mice (MVM) pre-mRNAs undergoes an unusual pattern of overlappi

102 Minute virus of mice (MVM) replicates via a linearized form of rolling-circle

103 autonomous parvovirus minute virus of mice (MVM) that were designed to introduce a neomycin resistan

104 its the binding of the minute virus of mice (MVM) to permissive cells but can also neutralize MVM pos

105 autonomous parvovirus minute virus of mice (MVM), a protein essential for viral replication and a po

106 bisense RNA virus, and minute virus of mice (MVM), a single-stranded DNA (ssDNA) parvovirus, but not

107 serotype 2 (AAV2) and Minute Virus of Mice (MVM), both T = 1 single stranded DNA viruses, and Bromo

108 autonomous parvovirus, minute virus of mice (MVM), forms viral replication centers in the nucleus whi

109 Parvoviruses, such as minute virus of mice (MVM), have adapted this mechanism to amplify their linea

110 ains of the parvovirus minute virus of mice (MVM), the immunosuppressive (MVMi) and the prototype (MV

111 exon of the parvovirus minute virus of mice (MVM), which is flanked by a large intron upstream and a

112 e parvovirus (CPV) and minute virus of mice (MVM).

113 pitulated in vitro for minute virus of mice (MVM).

114 nd the protoparvovirus minute virus of mice (MVM).

115 68 and the parvovirus minute virus of mice (MVM).

116 le-stranded parvovirus minute virus of mice (MVM).

117 ognition by parvovirus minute virus of mice (MVM).

118 , 31% of subjects used multivitamin mineral (MVM) products exclusively, 4% of subjects used single vi

119 Longer effects of multivitamin-mineral (MVM) supplementation on late-life cognitive function rem

120 rade (APRI+ALBI), based multivariable model (MVM) to predict PHLF and compare its performance to indo

121 polymerization (RP) of multivinyl monomers (MVMs) provides a facile solution for manipulating polyme

122 t the polymerization of multivinyl monomers (MVMs) would inevitably lead to insoluble cross-linked ge

123 Multivitamin-multimineral (MVM) supplements are widely used in the United States, o

124 lts commonly take multivitamin-multimineral (MVM) supplements to promote health, evidence on the use

125 g computing of matrix-vector multiplication (MVM) as they afford unparalleled speed and bandwidth den

126 s using analog matrix-vector multiplication (MVM) implementations are fundamentally limited in numeri

127 MVMi, MVMc, MVM-G17, tumor virus X (TVX), canine parvovirus (CPV), p

128 to permissive cells but can also neutralize MVM postattachment.

129 to A2) but not the major form (D1 to A1) of MVM mRNAs and is required for efficient definition of th

130 SMOS-Clinic, we observed a modest benefit of MVM compared with placebo on global cognition over 2 y {

131 Cajal bodies; however, during the course of MVM infection, dramatic nuclear alterations occur.

132 wo domains contain important determinants of MVM in vitro tropism (residues 317 and 321) and forward

133 nitive substudies for a robust evaluation of MVM effects on cognition.

134 f COSMOS substudies showed clear evidence of MVM benefits on global cognition [mean difference (95% C

135 One of MVM's activities in this regard is to inhibit one of the

136 may play a larger role in the host range of MVM than previously appreciated.

137 the successful expression and replication of MVM genomes at these cellular sites suggest that MVM int

138 sponse (DDR), stalling of the replication of MVM genomes with hydroxyurea (HU) resulted in Chk1 phosp

139 Here, we show that efficient replication of MVM requires binding of the host DNA repair protein MRE1

140 d by the 121-nucleotide left-end sequence of MVM, which folds into a Y-shaped hairpin containing smal

141 VMp) and immunosuppressive (MVMi) strains of MVM plus three virulent mutants of MVMp, MVMp-I362S, MVM

142 t also provides rationale for the tropism of MVM for malignant transformed cells that contain sLe(x)

143 eview articles that include an assessment of MVMs in relation to cancer and cardiovascular disease ar

144 lding reliable information on the effects of MVMs on chronic disease.

145 udies are needed to determine the effects of MVMs on other aging-related outcomes among older adults.

146 stablishing the health benefits and harms of MVMs requires accurate estimates of nutrient intake from

147 niques and their applications in FRP/RDRP of MVMs.

148 activation radical polymerizations (RDRP) of MVMs.

149 controlled trials and few cohort studies of MVMs that are directly pertinent to cancer or cardiovasc

150 Since then, the use of MVMs has largely been limited to as cross-linking agents

151 ld be encouraged to report available data on MVMs and chronic disease.

152 brief review of the available literature on MVMs in relation to incidence and mortality rates from p

153 reduced microvilli ("microvillus-minus," or MVM) but retaining normal tight junctions.

154 that required for normal, EV-transduced, or MVM-transduced cells.

155 In direct comparison with other MVM's based on more expensive and time-consuming liver f

156 Upon infection, the parvovirus MVM activates a cellular DNA damage response that govern

157 e discovered that the autonomous parvovirus, MVM, which is used to target cancer cells as an oncolyti

158 oth positive and negative values, to perform MVM computation in neural network algorithms.

159 g concept may be applied to various photonic MVM implementations to enable accurate optical computing

160 Accounting for placental MVM lesions did not impact results.

161 rical context to the problem of polymerizing MVMs, before highlighting how RDRP has led to the format

162 Multivitamin/mineral products (MVMs) are the dietary supplements most commonly used by

163 After adjusting for age, race, MVM lesions, body mass index, current hypertension, and

164 itor roscovitine after S-phase entry reduced MVM replication, suggesting that CDK activity was critic

165 We demonstrate colocalization of replicating MVM DNA with cellular double-strand breaks (DSBs) during

166 MRE11 binds to the replicating MVM genome at the P4 promoter, remaining distinct from R

167 that the host DDR interacts with replicating MVM molecules in ways that are distinct from viral genom

168 pon establishment of full viral replication, MVM infection prevented activation of Chk1 in response t

169 pon establishment of full viral replication, MVM infection prevented activation of Chk1 in response t

170 randomized controlled trial of well-selected MVMs in women may be warranted on public health grounds.

171 ions with microbial particles in suspension, MVM cells showed greatly enhanced adhesion and uptake of

172 ed for the oncotropic, cell nucleus-targeted MVM capsid may facilitate its development as a drug-enca

173 This study aimed to test MVM effects on cognitive change using in-person, detaile

174 Together our results suggest that MVM infection disables the ATR signaling pathway.

175 Our results suggest that MVM infection disables this important cellular signaling

176 genomes at these cellular sites suggest that MVM interacts with DDR machinery distinctly.

177 re, these structural differences between the MVM strains colocalize with tropism and pathogenicity de

178 eam NS2-specific exon can be achieved by the MVM small intron in its natural context, but not when it

179 For the MVM small intron in its natural context, the two donors

180 outcome occurred in 429 participants in the MVM group and 437 participants in the placebo group (HR:

181 e cancer occurred in 518 participants in the MVM group and 535 participants in the placebo group (HR:

182 All of the MVM capsids specifically bound to three structures with

183 a model in which alternative splicing of the MVM P4-generated pre-mRNAs is governed by a hybrid of in

184 An essential aspect of the MVM-induced DDR is establishment of a potent premitotic

185 An essential aspect of the MVM-induced DDR is the establishment of a potent premito

186 This article reports on the MVM intervention.

187 When the MVM small intron is expanded, various parameters of its

188 vement Program cohort, was compared with the MVM's based on other liver function tests (ICG clearance

189 AT2 subtypes of system L were distributed to MVM, with L-serine transport attributed to LAT2.

190 ut not mouse APOBEC3 conferred resistance to MVM.

191 Failure to activate Chk1 in response to MVM infection was likely due to our observation that Rad

192 tein expression is higher in first trimester MVM compared to term (P < 0.05).

193 ATR phosphorylation became undetectable upon MVM infection, and although virus infection induced RPA3

194 al in microvillous plasma membrane vesicles (MVM) from normal human placenta using a method which exp

195 and the third was 4-methyl-3-vinylmaleimide (MVM), a previously isolated photodegradation product of

196 in MNR compared to controls at GD170, as was MVM FATP2 and FATP6 expression at GD140 and FATP2 expres

197 ncies (HPRT mutant colonies) were lower with MVM vectors, and the noncoding strand frequency was thre

198 ns or minerals solely or in combination with MVMs, and 2% of subjects used nonvitamin, nonmineral pro